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The immunological properties of a glycoprotein fraction and of proteoglycan subunits obtained from bovine 
nasal cartilage by nondisruptive methods of isolation have been studied. Using the techniques of hemagglutination 
and hemagglutination i hibition, we found that the glycoprotein contains most of the species-specific determinants, 
whereas the proteoglycan subunits contain most of the cross-reacting ones. 
1. Introduction 
A major part of cartilage matrix consists of proteo- 
glycan complex (PGC) which contains chondroitin sul- 
fate covalently linked to noncollagenous protein. The 
slowly sedimenting fraction of this complex has been 
called proteinpolysaccharide-light (PPL) [l] . Various 
laboratories have demonstrated that antisera to PPL 
contain at least two types of antibodies: one directed 
against species-specific determinants and the other 
directed against determinants common to different 
species [2-51. It has been reported that both antigenic 
sites are destroyed by treatment with various proteo- 
lytic enzymes, but remain intact after treatment with 
testicular hyaluronidase [4-71 . Thus, the latter en- 
zyme has been widely employed to obtain antigens 
more suitable for immunodiffusion or hemagglutination 
techniques [5-71 . Recent studies, however, have in- 
dicated that treatment of PPL with testicular hay- 
luronidase causes a loss of species-specific and cross- 
reacting determinants [8], possibly becase of confor- 
mational changes of the protein residue as a result of 
the removal of part of the chondroitin sulfate chains. 
This finding emphasizes the importance of performing 
immunochemical work with proteoglycan preparations 
which have not been subjected to disruptive methods 
of isolation [9] or to the action of proteolytic en- 
zymes present in cartilage [ 10, 1 l] . 
For these reasons the PGC extracted from bovine 
nasal cartilage by dissociative, nondisruptive, methods 
[93 is particularly suitable for the continuation of our 
studies. The complex has a low protein content (8%). 
Moreover, this complex, in which the proteoglycan is 
partially aggregated may be separated by equilibrium 
centrifugation in a density gradient into two different 
fractions [ 121: a glycoprotein link (GPL) and proteo- 
glycan subunits (PGS). The latter preparation contains 
only 5% protein, and accounts for 95% of the hexu- 
ronic acid present in the complex, but it cannot reag 
gregate unless the glycoprotein link is present. 
This present report describes the immunological 
properties of the glycoprotein link and the proteo- 
glycan subunits obtained from bovine proteoglycan 
complex. 
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2. Methods Table 1 
Hemagglutination of erythrocytes coated with components 
The techniques used for isolation of PGC, GPL and 
PGS from bovine nasal septa have been published [9, 
121 . Antisera to bovine or human PPL were prepared 
by injection of white rabbits (5 kg) with 1 ml of 
Freund’s adjuvant containing 1 mg of either human 
or bovine PPL. Injections were given weekly for four 
weeks. One month after the last injection, the rabbits 
received a booster injection of 1 mg antigen, and after 
another month they were bled. 
of proteoglycan complex. 
Erythrocyte-coating 
preparation 
Titer of antiserum 
Anti-bovine PPL Anti-human PPL 
-~ 
Bovine GPL 
Bovine PGS 
1:20,480 1:1,280 
1:5,120 1: 10,240 
____ 
The immune sera were inactivated, absorbed with 
lyophilized [5] or polymerized [ 131 bovine or human 
plasma and then absorbed with fresh group 0 human 
erythrocytes. 
The details of the hemagglutination and hemagglu- 
tination inhibition tests have been described previous- 
ly [3]. Tanned human erythrocytes could not be coated 
with PCS by these techniques, perhaps because of the 
low protein content. Instead, glutaraldehyde-fixed, un- 
tanned human erythrocytes [ 141 were coated as fol- 
lows. One ml of a 2.5% suspension of glutaraldehyde- 
fixed erythrocytes in saline was added to 4 ml of phos- 
phate-buffered saline at pH 6.4 containing 3 mg of 
PGS. The cells were incubated for 18 hr at room tem- 
perature, collected by centrifugation, washed twice 
with 1:200 normal rabbit serum, and suspended in 1 
ml of the same. Aliquots of 0.10 ml were added to 
0.90 ml of antiserum dilutions. Glutaraldehyde-fixed 
erythrocytes were coated with GPL by the same tech- 
nique, but the GPL concentration was 0.5 mg in 4 ml, 
and the incubation was for 2 hr. Higher concentrations 
of GPL caused spontaneous hemagglutination. 
ever, that PGS also has some species-specific deter- 
minants, unless its reactivity with anti-bovine PPL im- 
mune serum can be attributed to a contamination 
with GPL. The possibility that PGS is grossly conta- 
minated with GPL is eliminated by the hemagglutina- 
tion inhibition experiments (table 2), which indicate 
that 2 pg/ml of bovine GPL are sufficient to inhibit 
the agglutination of PGS-coated erythrocytes by anti- 
bovine PPL immune serum but that 250 pg/ml of 
bovine PGS are required to inhibit the agglutination 
of GPL-coated erythrocytes by the same immune 
serum. The results indicate rather that PGS and GPL 
have a very low level of similar species-specific deter- 
minants and that GPL possesses a high level of species- 
specific determinants different from those present on 
PGS. 
Erythrocytes coated with GPL or PGS were added 
to increasing dilutions of the two immune sera. The 
results of hemagglutination are presented in table 1. 
GPL and PGS were used in progressively decreasing 
amounts as inhibitors of the systems: anti-bovine PPL 
immune serum, or anti-human PPL immune serum, 
versus red cells coated respectively with PCS or GPL. 
The results are presented in table 2. 
When the hemagglutination inhibition experiments 
were performed with anti-human PPL immune serum 
at 1:400 dilution, 8 &ml of bovine GPL were required 
to inhibit the agglutination of PGS-coated erythrocytes; 
with anti-human PPL immune serum at 1:80 dilution, 
2 I.cg/ml of PGS were sufficient to inhibit the agglutina- 
tion of GPL-coated erythrocytes. These results indicate 
that both fractions have cross-reacting antigenic deter- 
minants and that these are most abundant on PGS. 
3. Results and discussion 
The species-specific determinants are mostly located 
on the glycoprotein, while the cross-reacting ones are 
present on the proteoglycan (table 1). It is clear, how- 
The chondroitin sulfate chains present in PGS are 
known to be structurally similar in various species; 
our results indicate that even the small protein moiety 
of these subunits seems to be immunologically similar 
in various species. The immunological determinants 
which are unique to GPL suggest additional considera- 
tions and dictate the direction for further experiments. 
It is conceivable that, in the native arrangement of 
PGC, the GPL molecules are shielded by the dense 
cloud of negative charges of the PGS. If this were the 
case, the immunocompetent cells of the organism 
could not detect GPL under normal conditions, but 
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Table 2 
Inhibition of hemagglutination by components of proteoglycan complex. 
Erythrocyte-coating 
preparation 
Antiserum and titer Inhibitor (&ml) 
Results of 
hemagglutination 
Bovine GPL Anti-bovine PPL, 1:400 Bovine PGS 25 0 _ 
125 + 
Anti-human PPL, 1:80 4 _ 
2 -t 
Bovine PGS Anti-bovine PPL, 1:400 
Anti-human PPL, 1:400 
would immediately recognize it as “foreign” if, under 
pathological conditions, it became exposed. 
The high titer of antibodies against GPL present in 
our antisera is not contrary to the latter hypothesis, 
because the antisera were produced against PPL, a dis- 
rupted and desorganized preparation in which GPL 
might have become mechanically exposed during the 
process of isolation. The necessity of using PGC rather 
than PPL as immunizing antigens and the opportunity 
of investigating the possible antigenicity of homologous 
GPL are evident. 
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